The central target comes from five individual analyst forecasts rather than a single consensus figure. Recent targets include Barclays at $0.30 (Sell), Maxim Group at $3.00 (Buy), Jefferies at $0.81 (Hold), Stephens at $1.00 (Hold), and Mizuho at $1.00 (Hold). Adding them up yields a mean near $1.22, which rounds to the $1.20 headline level.
That $0.30-to-$3.00 spread is unusually wide and highlights how differently analysts view the situation. Some targets predate the sharper distress signals that emerged in October 2026, so they may not fully capture the current risks.
HAIN closed near $0.15 ahead of the November 9, 2026 earnings release and moved to roughly $0.13–$0.14 afterward. From that level, $1.20 would represent a gain of about 750%. The 52-week range sits between $0.12 and $1.48, and market capitalization has fallen to around $13 million.
Fiscal Q1 2027 adjusted EPS came in at -$0.07 versus a -$0.03 consensus, while revenue of $260.3 million missed expectations. Organic sales declined 6.7% year over year, though adjusted gross margin improved 320 basis points to 22.8%. Progress on the balance sheet will matter far more than quarterly results for any move toward the target.
Margin gains appear real, with North American adjusted gross margin reaching 33.5%. The company has also removed stranded costs from its former snacks business. Brands including Greek Gods and Ella's Kitchen posted growth, and e-commerce sales rose more than 30%. A completed sale of the International segment to AURELIUS for roughly $323 million could reduce debt and allow greater focus on North America. If a restructuring leaves meaningful equity value intact, shares could re-rate from current levels.
The challenges remain serious. HAIN missed an October 12, 2026 deadline to amend its credit agreement, and reports indicate the company is considering Chapter 11 options. The auditor raised going-concern doubts, and about $655 million in debt matures in December. Free cash flow was negative $23 million in the quarter, with net secured leverage at 5.3x. Nasdaq has given the company until March 2027 to regain a $1.00 bid price, raising delisting risk. In bankruptcy, common equity could be heavily impaired or wiped out.
The stock trades well below its 52-week high and sits just above the $0.12 low that serves as near-term support. The $1.00 level carries extra weight as the Nasdaq minimum bid price threshold. Traditional technical analysis takes a back seat to capital-structure developments in this environment.
Analyst targets generally look out about 12 months, but the relevant horizon here is much shorter. Near-term focus points include the December debt maturity, lender negotiations, whether the International sale closes, any Chapter 11 filing, and Nasdaq compliance decisions. Earnings and revisions matter, yet capital-structure events will likely determine whether equity value survives.
In my own work, I sometimes reference Tickeron’s AI Daily Buy/Sell Signals when following event-driven situations. The platform applies artificial intelligence to scan market conditions and technical behavior across many securities, which can help surface timely observations alongside fundamental analysis.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
HAIN moved below its 50-day moving average on October 13, 2026 date and that indicates a change from an upward trend to a downward trend. In 35 of 40 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 88%.
The Momentum Indicator moved below the 0 level on October 15, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HAIN as a result. In 70 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HAIN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Aroon Indicator for HAIN entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 43 of 62 cases where HAIN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 69%.
The Moving Average Convergence Divergence (MACD) for HAIN just turned positive on November 04, 2026. Looking at past instances where HAIN's MACD turned positive, the stock continued to rise in 28 of 40 cases over the following month. The odds of a continued upward trend are 70%.
Following a +12.01% 3-day Advance, the price is estimated to grow further. Considering data from situations where HAIN advanced for three days, in 160 of 240 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
HAIN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 39 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.088) is normal, around the industry mean (6.914). P/E Ratio (-0.044) is within average values for comparable stocks, (7.137). Projected Growth (PEG Ratio) (1.223) is also within normal values, averaging (8.458). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (0.039) is also within normal values, averaging (5.003).
The Tickeron Price Growth Rating for this company is 97 (best 1 - 100 worst), indicating slightly worse than average price growth. HAIN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HAIN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of organic snack food and personal care products
Industry FoodMajorDiversified